Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|January 1, 1990
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinosideS Kirmani, S Zimm, S M Cleary, et al.Cancer Research|January 1, 1988
Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patientsT C Chan, G L Coppoc, S Zimm, et al.Cancer Research|November 1, 1984
Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkeyI G Kerr, S Zimm, J M Collins, et al.Clinical Pharmacology and Therapeutics|December 1, 1983
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinolS Zimm, J M Collins, D O'Neill, et al.Cancer Research|April 1, 1984
Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinoneS Zimm, J M Collins, G A Curt, et al.Cancer Drug Delivery|January 1, 1986
The effect of amitriptyline on the central nervous system penetration of methotrexateR L Heideman, F M Balis, S Zimm, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Selective intraperitoneal biochemical modulation of methotrexate by dipyridamoleR Goel, S M Cleary, C Horton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapyS B Howell, S Zimm, M Markman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignanciesS L Berg, F M Balis, S Zimm, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumorsP C Adamson, S Zimm, A H Ragab, et al.Pageof 3